Analysts cheer ‘surprisingly positive’ AstraZeneca U.S. trial data
March 22, 2021 at 09:13 AM EDT
Jefferies healthcare analyst Peter Welford said the analysis of the AstraZeneca shot, published Monday, was better than expected.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|